Key result
Plasma clearance of Ang II in spontaneously hypertensive rats was significantly greater with PD123319, losartan+PD123319, or Sar1-Thr8-Ang II compared to saline or losartan.
Why the study?
Does AT1 or AT2 receptor blockade alter the plasma clearance of Angiotensin II in spontaneously hypertensive rats?
Does AT1 or AT2 receptor blockade alter the plasma clearance of Angiotensin II in spontaneously hypertensive rats?
In spontaneously hypertensive rats, plasma clearance of Angiotensin II is independent of AT1 receptors but protected by an AT2 receptor-dependent mechanism.
Ang II clearance in SHRs is AT1-independent; leaves open receptor-specific modulation of peptide metabolism in hypertension.
This study assessed the role of angiotensin (Ang) AT1 and AT2 receptors as modulators of the plasma clearance of Ang II. Groups of male spontaneously hypertensive rats (SHRs; n = 25) were given an intravenous injection of either saline, losartan, PD123319, losartan in combination with PD123319, or Sar1-Thr8-Ang II. One hour later, Ang II (0.5 microg/kg) was infused for 15 min into a vein. Immediately thereafter, arterial blood samples were collected at regular intervals for the assay of plasma Ang II levels by radioimmunoassay. The infusion of Ang II significantly increased baseline mean arterial pressure (MAP) in rats pretreated with either saline or PD123319 but not in those receiving losartan, losartan combined with PD123319, or Sar1-Thr8-Ang II. The plasma clearance of Ang II was significantly greater in rats injected with either PD123319, losartan combined with PD123319, or Sar1-Thr8-Ang II compared to those injected either saline or losartan. Furthermore, the half-life of Ang II in rats pretreated with saline or losartan was significantly greater than that measured in the other three groups. These results suggest that plasma clearance of Ang II in the SHRs is independent of an AT1 receptor, but plasma levels of the peptide are unexpectedly protected by an AT2 receptor-dependent mechanism.
No takes yet. Share an insight, caveat, or question.
Iyer et al. (1998) studied Hypertension (n=25). Losartan, PD123319, Losartan + PD123319, or Sar1-Thr8-Ang II vs. Saline was evaluated on Plasma clearance and half-life of Angiotensin II. Plasma clearance of Ang II in spontaneously hypertensive rats was significantly greater with PD123319, losartan+PD123319, or Sar1-Thr8-Ang II compared to saline or losartan.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: